Guidance

Hepatitis A/B vaccine: patient group direction template

Patient group direction (PGD) template to support the provision of hepatitis A and B (HepA/B) vaccine to individuals pre- and post-exposure to HepA/B.

Documents

HepA/B vaccine PGD

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

HepA/B vaccine (temp) PGD

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The HepA/B vaccine PGD supports the provision of HepA/B vaccine to individuals aged over-one-year requiring pre-exposure immunisation against hepatitis A and B virus.

The HepA/B vaccine PGD is valid from 1 November 2017 to 31 October 2019.

The HepA/B vaccine (temp) has been issued for use during shortages of hepatitis vaccine affecting UK supply. It supports the administration of HepA/B vaccine to individuals requiring pre-exposure or post-exposure immunisation against hepatitis A or B virus in accordance with PHE temporary dose sparing advice, to preserve and prioritise monovalent hepatitis vaccine stock for those with the greatest ability to benefit and highest immediate need.

The HepA/B vaccine (temp) PGD is valid from 1 November 2018 to 31 October 2020.

Practitioners must not use these PGD templates until they have been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.

These PGD templates should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 13 November 2017
Last updated 11 October 2018 + show all updates
  1. Added routine update of the HepA/B vaccine (temp) PGD.
  2. First published.